Kingstone Capital Partners Texas, LLC Exact Sciences Corp Transaction History
Kingstone Capital Partners Texas, LLC
- $624 Billion
- Q2 2025
A detailed history of Kingstone Capital Partners Texas, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Kingstone Capital Partners Texas, LLC holds 273,936 shares of EXAS stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273,936Holding current value
$11.3 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
642Shares Held
160MCall Options Held
1.69MPut Options Held
1.42M-
Capital World Investors Los Angeles, CA18.2MShares$754 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$742 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$518 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$500 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$274 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...